Rocket Lab Corp
$38.41B- Market cap
- $39.43B
- Debt
- +$1.72M
- Cash
- −$1.02B
Capital structure 100% equity / 0% debt · EV / Revenue 63.83x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $39.43B · View financials
Snapshot Sep 8, 2026, 3:58 PM ET
FY 2026 · Mkt cap
Decision snapshot: RKLB stock price at premium vs DOCS $65.89 current versus $6.86 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DOCS's multiple
Implied fair value · at RKLB's multiple
Snapshot Sep 8, 2026, 3:58 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: RKLB FY 2025 (ended Dec 31, 2025) · DOCS FY 2026 (ended Mar 31, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 100% equity / 0% debt · EV / Revenue 63.83x
Capital structure 99% equity / 1% debt · EV / Revenue 6.55x · EV / EBITDA 15.44x
RKLB carries the larger enterprise value at $38.41B against $4.22B; DOCS trades on the lower EV / Revenue multiple (6.55x vs 63.83x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Rocket Lab Corp · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Doximity, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.00x
0.05x
Net debt / EBITDA
Leverage against operating earnings
6.55x
-0.64x
Cash and equivalents
Liquid reserves on the balance sheet
$1.02B
$219.18M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
NORTHROP GRUMMAN CORP /DE/
RKLB vs NOC
BOEING CO
RKLB vs BA
LOCKHEED MARTIN CORP
RKLB vs LMT
L3HARRIS TECHNOLOGIES, INC. /DE/
RKLB vs LHX
Virgin Galactic Holdings, Inc
RKLB vs SPCE
HEALTHEQUITY, INC.
RKLB vs HQY
Teladoc Health, Inc.
RKLB vs TDOC
Hims & Hers Health, Inc.
RKLB vs HIMS
GoodRx Holdings, Inc.
RKLB vs GDRX
$1.72M
$44.32M
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.